Peter Linde is Chief Medical Officer of Morphic Holding, Inc.. Currently has a direct ownership of 11,272 shares of MORF, which is worth approximately $384,037. The most recent transaction as insider was on Sep 16, 2021, when has been sold 4,000 shares (Common Stock) at a price of $65.92 per share, resulting in proceeds of $263,680. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.3K
0% 3M change
0% 12M change
Total Value Held $384,037

Peter Linde Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2021
SELL
Open market or private sale
$263,680 $65.92 p/Share
4,000 Reduced 26.19%
11,272 Common Stock
Sep 16 2021
BUY
Exercise of conversion of derivative security
-
10,378 Added 40.46%
15,272 Common Stock
Jun 01 2021
SELL
Open market or private sale
$300,060 $50.01 p/Share
6,000 Reduced 56.6%
4,600 Common Stock
Mar 16 2021
SELL
Open market or private sale
$786,000 $65.5 p/Share
12,000 Reduced 53.1%
10,600 Common Stock
Mar 16 2021
BUY
Exercise of conversion of derivative security
-
21,743 Added 49.03%
22,600 Common Stock
PL

Peter Linde

Chief Medical Officer
Waltham, MA

Track Institutional and Insider Activities on MORF

Follow Morphic Holding, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MORF shares.

Notify only if

Insider Trading

Get notified when an Morphic Holding, Inc. insider buys or sells MORF shares.

Notify only if

News

Receive news related to Morphic Holding, Inc.

Track Activities on MORF